XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
CURRENT ASSETS    
Cash and cash equivalents $ 19,337 $ 20,922
Research and development tax credit receivable 1,283 1,181
Other tax receivable 133 228
Prepaid expenses and other current assets 207 331
TOTAL CURRENT ASSETS 20,960 22,662
Operating lease – right of use asset 278 307
Other assets 49 79
Acquired in-process research and development intangible assets 16,514 16,514
TOTAL ASSETS 37,801 39,562
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 7,198 6,539
Deferred liabilities 480 517
Operating lease, current liabilities 146 140
TOTAL CURRENT LIABILITIES 7,927 7,221
Long-term operating lease liability 201 244
TOTAL LIABILITIES 8,128 7,465
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.001 par value, 200,000,000 shares authorized, 22,930,411 and 22,280,451 shares issued and outstanding, respectively 23 22
Additional paid-in capital 203,103 195,754
Accumulated other comprehensive loss (610) (575)
Accumulated deficit (172,843) (163,104)
TOTAL STOCKHOLDERS’ EQUITY 29,673 32,097
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 37,801 39,562
Related Party    
CURRENT LIABILITIES    
Accounts payable and accrued liabilities – related parties $ 103 $ 25